May 10, 2023 — Advisors from the FDA made strides today toward approving the country’s first over-the-counter birth control pill, voting unanimously that widening the pill’s availability would provide more benefits than harm.
The FDA approval of the oral contraceptive Opill – a 0.075mg daily tablet also called the “mini pill” as it only contains the hormone progestin (rather than a combination of progestin and estrogen) – could happen as soon as this summer. While the agency is not bound by the advisory panel’s recommendations, a 17-0 vote will lend serious credence to the pill.
HRA Pharma, the French drug company that…
